نتایج جستجو برای: htlv 1 protease

تعداد نتایج: 2785192  

Journal: :Journal of virology 2008
Sebastian C Y Ku Jialing Lee Joanne Lau Meera Gurumurthy Raymond Ng Siew Hui Lwa Joseph Lee Zachary Klase Fatah Kashanchi Sheng-Hao Chao

X-box binding protein 1 (XBP-1), a basic leucine zipper transcription factor, plays a key role in the cellular unfolded protein response (UPR). There are two XBP-1 isoforms in cells, spliced XBP-1S and unspliced XBP-1U. XBP-1U has been shown to bind to the 21-bp Tax-responsive element of the human T-lymphotropic virus type 1 (HTLV-1) long terminal repeat (LTR) in vitro and transactivate HTLV-1 ...

2014
Aline Garcia Kozlowski Megmar Aparecida dos Santos Carneiro Márcia Alves Dias de Matos Sheila Araújo Teles João Alves Araújo Koko Otsuki Ana Carolina Paulo Vicente Regina Maria Bringel Martins

Human T-cell lymphotropic virus (HTLV) may impact the clinical course of tuberculosis (TB). Both infections are highly endemic in Brazil. The aim of this study was to assess the prevalence of HTLV-1/2 in TB patients in Central-West Brazil and to perform a genetic characterisation of the respective isolates. Of the 402 patients, six (1.49%) were positive for anti-HTLV and five (1.24%; 95% confid...

Journal: :Journal of clinical microbiology 2003
Daniel R Kuritzkes Robert M Grant Paul Feorino Marshal Griswold Marie Hoover Russell Young Stephen Day Robert M Lloyd Caroline Reid Gillian F Morgan Dean L Winslow

The TRUGENE HIV-1 Genotyping Kit and OpenGene DNA Sequencing System are designed to sequence the protease (PR)- and reverse transcriptase (RT)-coding regions of human immunodeficiency virus type 1 (HIV-1) pol. Studies were undertaken to determine the accuracy of this assay system in detecting resistance-associated mutations and to determine the effects of RNA extraction methods, anticoagulants,...

Journal: :Revista do Instituto de Medicina Tropical de Sao Paulo 2007
Helena Kaminami Morimoto Arilson Akira Morimoto Edna Maria Vissoci Reiche Luiz Toshio Ueda Tiemi Matsuo Fernando Vissoci Reiche Adele Caterino-de-Araujo

The current diagnosis of human T-lymphotropic virus type-2 (HTLV-2) infection is based on the search of specific antibodies; nevertheless, several studies conducted in Brazil pointed deficiencies of the commercially available kits in detecting HTLV-2, mostly in HIV/AIDS patients. This study searched for the presence of HTLV-1 and -2 in 758 HIV/AIDS patients from Londrina, Paraná, Brazil. Serum ...

2018
Lloyd Einsiedel Damian Purcell Shane Schinke Katelin Haynes Graham P Taylor Fabiola Martin

We are pleased to report on the inaugural HTLV-1 symposium at the 2017 Australasian HIV and AIDS Conference joint with 2017 Australasian Sexual Health Conference in Canberra, Australia. Our understanding of HTLV-1 epidemiology, pathogenesis, laboratory diagnostics and treatment options for HTLV-1 diseases has advanced tremendously over the last 40 years. However, the awareness of healthcare pro...

2013
Nicolas A. Gillet Lucy Cook Daniel J. Laydon Carol Hlela Kristien Verdonck Carolina Alvarez Eduardo Gotuzzo Daniel Clark Lourdes Farré Achiléa Bittencourt Becca Asquith Graham P. Taylor Charles R. M. Bangham

Human T-lymphotropic Virus-1 (HTLV-1) is a retrovirus that persists lifelong by driving clonal proliferation of infected T-cells. HTLV-1 causes a neuroinflammatory disease and adult T-cell leukemia/lymphoma. Strongyloidiasis, a gastrointestinal infection by the helminth Strongyloides stercoralis, and Infective Dermatitis associated with HTLV-1 (IDH), appear to be risk factors for the developmen...

2011
A. Gessain

Human T-cell leukemia/lymphoma virus type 1 (HTLV-1) was the first oncogenic human retrovirus discovered in 1980. It is estimated that around 10–20 million people are infected with HTLV-1 worldwide. However, HTLV-1 is not a ubiquitous virus. Indeed, HTLV-1 is present throughout the world with clusters of high endemicity including mainly southern Japan, the Caribbean region, parts of South Ameri...

2017
Gergès Rizkallah Sandrine Alais Nicolas Futsch Yuetsu Tanaka Chloé Journo Renaud Mahieux Hélène Dutartre

Human T lymphotropic Virus type 1 (HTLV-1) is the etiological agent of Adult T cell Leukemia/Lymphoma (ATLL) and HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). Both CD4+ T-cells and dendritic cells (DCs) infected with HTLV-1 are found in peripheral blood from HTLV-1 carriers. We previously demonstrated that monocyte-derived IL-4 DCs are more susceptible to HTLV-1 infection...

Journal: :The Journal of Experimental Medicine 1993
I Elovaara S Koenig A Y Brewah R M Woods T Lehky S Jacobson

The frequencies of human T cell lymphotropic virus type 1 (HTLV-1)-specific CD8+ precursor cytotoxic T lymphocytes (pCTL) were quantitated from lymphocytes obtained from the peripheral blood and cerebrospinal fluid (CSF) of infected individuals with and without HTLV-1-associated neurological disease. An estimate of the pCTL was obtained by separating CD8+ cells, plating these cells in limiting ...

Journal: :Antiviral therapy 2012
Ahu Demir Raphael M Oguariri Andrew Magis David A Ostrov Tomozumi Imamichi Ben M Dunn

BACKGROUND Human T-cell leukemia virus-1 (HTLV-1) was the first identified human retrovirus and was shown to be associated with diseases such as adult T-cell leukemia lymphoma and tropical spastic paraparesis/HTLV-1 associated myelopathy. Retroviral proteases (PRs) are essential for viral replication by processing viral Gag and Gag-(Pro)-Pol polyproteins during maturation. Full-length HTLV-1 PR...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید